A randomized controlled multicenter study comparing recombinant interleukin 2 (rIL-2) in conjunction with recombinant interferon alpha (IFN-α) versus no immunotherapy for patients with malignant lymphoma postautologous stem cell transplantation

1. Nagler, A.
2. Berger, R.
3. Ackerstein, A.
4. Czyz, J.A.
5. Diez-Martin, J.L.
6. Naparstek, E.
7. Or, R.
8. Gan, S.
9. Shimoni, A.
10. Slavin, S.